Qing Zhao, MD, PhD

Clinical Associate Professor, Pathology & Laboratory Medicine

617.414.5339
670 Albany St Biosquare III

Other Positions

  • Section Chief, Anatomic Pathology, Pathology & Laboratory Medicine, Boston Medical Center
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Jilin University, MD
  • McGill University, PhD
  • Jilin University, MSc

Publications

  • Published on 3/20/2024

    Shaikh SD, Jacoba I, Sun N, Chung E, Kim HT, Zhao Q, Weber HC. A Clinicopathological Appraisal of Duodenal Neuroendocrine Tumors at a Racially Diverse Safety Net Hospital. Am J Gastroenterol. 2024 Mar 20. PMID: 38345246.

    Read at: PubMed
  • Published on 11/13/2023

    Ma L, Sullivan TB, Rieger-Christ KM, Yambayev I, Zhao Q, Higgins SE, Yilmaz OH, Sultan L, Servais EL, Suzuki K, Burks EJ. Vascular invasion predicts the subgroup of lung adenocarcinomas =2.0 cm at risk of poor outcome treated by wedge resection compared to lobectomy. JTCVS Open. 2023 Dec; 16:938-947. PMID: 38204657.

    Read at: PubMed
  • Published on 12/13/2022

    Dang RR, Kim J, Qureshi MM, Fazeli SR, Zhao Q, Noonan VL, Sundararajan D, Salama A, Truong MT. Impact of depth of invasion on local recurrence in R0 resected node-negative oral tongue squamous cell carcinoma. Head Neck. 2023 Mar; 45(3):561-566. PMID: 36513522.

    Read at: PubMed
  • Published on 7/20/2022

    Yilmaz O, Crabbe A, Neyaz A, Pankaj A, Lee SH, Hosseini S, Rickelt S, Cerda S, Zhao Q, Leijsen L, Dineaux A, Shroff SG, Crotty R, Zhang ML, Yilmaz OH, Patil DT, Berger D, Deshpande V. Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon. Histopathology. 2022 Sep; 81(3):380-388. PMID: 35789111.

    Read at: PubMed
  • Published on 7/9/2022

    Lee SH, Vadlamudi C, Zhao Q, Yilmaz O, Cerda S. An institutional experience with DICER1 mutated thyroid nodules-evaluating the cytomorphology and molecular phenotype. J Am Soc Cytopathol. 2022; 11(6):335-344. PMID: 35934646.

    Read at: PubMed
  • Published on 6/30/2022

    Yilmaz O, Pankaj A, Neyez A, Rickelt S, Taylor M, Lang ER, Leijsen L, Dinaux A, Shroff SG, Crotty R, Zhang ML, Cerda S, Zhao Q, Ferrone C, Ting DT, Patil DT, Yilmaz O, Berger D, Deshpande V. Programmed death-ligand 1 expression in the immune compartment of colon carcinoma. Mod Pathol. 2022 Nov; 35(11):1740-1748. PMID: 35773332.

    Read at: PubMed
  • Published on 6/13/2022

    Lotfollahzadeh S, Lo D, York EA, Napoleon MA, Yin W, Elzinad N, Le J, Zhang M, Yang X, Morrissey A, Elsadawi M, Zhao Q, Schaus SE, Hansen U, Chitalia VC. Pharmacologic Manipulation of Late SV40 Factor Suppresses Wnt Signaling and Inhibits Growth of Allogeneic and Syngeneic Colon Cancer Xenografts. Am J Pathol. 2022 Aug; 192(8):1167-1185. PMID: 35710032.

    Read at: PubMed
  • Published on 9/24/2021

    Mackel CE, Medeiros I, Moore BE, Zhao Q, Jha R. Intracranial Malignant Peripheral Nerve Sheath Tumors Not Associated with a Cranial Nerve: Systematic Review and Illustrative Case. World Neurosurg. 2021 12; 156:76-91. PMID: 34563719.

    Read at: PubMed
  • Published on 7/14/2021

    Kritselis M, Yambayev I, Prilutskiy A, Shevtsov A, Vadlamudi C, Zheng H, Elsadwai M, Ma L, Aniskovich E, Kataria Y, Higgins S, Sarita-Reyes C, Zuo T, Zhao Q, Quillen K, Burks EJ. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19. Hum Pathol. 2021 10; 116:49-62. PMID: 34273395.

    Read at: PubMed
  • Published on 6/30/2021

    Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, Olejnik J, Chandler KB, Xia C, Feldman J, Hauser BM, Caradonna TM, Schmidt AG, Gummuluru S, Mühlberger E, Chitalia V, Costello CE, Rahimi N. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. ACS Cent Sci. 2021 Jul 28; 7(7):1156-1165. PMID: 34341769.

    Read at: PubMed

View 23 more publications: View full profile at BUMC

View all profiles